Search research articles
Contact Us
Filters
Showing results (71-80 of 86) with videos related to
Page
of 9
Sort By:
The Oncologist
|
August 22, 2018
A Phase II Trial of Sorafenib and Dacarbazine for Leiomyosarcoma, Synovial Sarcoma, and Malignant Peripheral Nerve Sheath Tumors
David R D'Adamo, Mark A Dickson, Mary L Keohan, et al.
Cancer Discovery
|
June 23, 2019
V211D Mutation in MEK1 Causes Resistance to MEK Inhibitors in Colon Cancer
Yijun Gao, Ann Maria, Na Na, et al.
European Urology
|
October 19, 2024
Corrigendum to "Cabozantinib Plus Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma: Updated Results from a Phase II Trial" [Eur. Urol. 86(2) (2024) 90-94]
Kelly N Fitzgerald, Chung-Han Lee, Martin H Voss, et al.
European Urology
|
May 23, 2024
Cabozantinib Plus Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma: Updated Results from a Phase 2 Trial
Kelly N Fitzgerald, Chung-Han Lee, Martin H Voss, et al.
Melanoma Research
|
October 30, 2016
Clinical features and response to systemic therapy in a historical cohort of advanced or unresectable mucosal melanoma
Alexander N Shoushtari, Mark J Bluth, Debra A Goldman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2022
Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non-Clear-Cell Renal Cell Carcinoma and Genomic Correlates
Chung-Han Lee, Martin H Voss, Maria Isabel Carlo, et al.
Cancer Immunology Research
|
January 18, 2018
Robust Antitumor Responses Result from Local Chemotherapy and CTLA-4 Blockade
Charlotte E Ariyan, Mary Sue Brady, Robert H Siegelbaum, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2022
A Phase Ib/II Randomized Study of RO4929097, a Gamma-Secretase or Notch Inhibitor with or without Vismodegib, a Hedgehog Inhibitor, in Advanced Sarcoma
Mrinal M Gounder, Evan Rosenbaum, Nian Wu, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 22, 2014
⁸⁹Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer
Neeta Pandit-Taskar, Joseph A O'Donoghue, Volkan Beylergil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 15, 2024
Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with Sarcoma
Sujana Movva, Kenneth Seier, Viswatej Avutu, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 86) with videos related to
Sort By:
Page
of 9
The Oncologist
|
August 22, 2018
A Phase II Trial of Sorafenib and Dacarbazine for Leiomyosarcoma, Synovial Sarcoma, and Malignant Peripheral Nerve Sheath Tumors
David R D'Adamo, Mark A Dickson, Mary L Keohan, et al.
Cancer Discovery
|
June 23, 2019
V211D Mutation in MEK1 Causes Resistance to MEK Inhibitors in Colon Cancer
Yijun Gao, Ann Maria, Na Na, et al.
European Urology
|
October 19, 2024
Corrigendum to "Cabozantinib Plus Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma: Updated Results from a Phase II Trial" [Eur. Urol. 86(2) (2024) 90-94]
Kelly N Fitzgerald, Chung-Han Lee, Martin H Voss, et al.
European Urology
|
May 23, 2024
Cabozantinib Plus Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma: Updated Results from a Phase 2 Trial
Kelly N Fitzgerald, Chung-Han Lee, Martin H Voss, et al.
Melanoma Research
|
October 30, 2016
Clinical features and response to systemic therapy in a historical cohort of advanced or unresectable mucosal melanoma
Alexander N Shoushtari, Mark J Bluth, Debra A Goldman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2022
Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non-Clear-Cell Renal Cell Carcinoma and Genomic Correlates
Chung-Han Lee, Martin H Voss, Maria Isabel Carlo, et al.
Cancer Immunology Research
|
January 18, 2018
Robust Antitumor Responses Result from Local Chemotherapy and CTLA-4 Blockade
Charlotte E Ariyan, Mary Sue Brady, Robert H Siegelbaum, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2022
A Phase Ib/II Randomized Study of RO4929097, a Gamma-Secretase or Notch Inhibitor with or without Vismodegib, a Hedgehog Inhibitor, in Advanced Sarcoma
Mrinal M Gounder, Evan Rosenbaum, Nian Wu, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 22, 2014
⁸⁹Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer
Neeta Pandit-Taskar, Joseph A O'Donoghue, Volkan Beylergil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 15, 2024
Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with Sarcoma
Sujana Movva, Kenneth Seier, Viswatej Avutu, et al.
Page
of 9